{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":788,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":788,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"2b5dedba5d46","filters":{"venue":"European Journal of Heart Failure"}},"results":[{"id":"W4210520398","doi":"10.1002/ejhf.2333","title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":2134,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"European Association of Cardiovascular Imaging","keywords":"Kingdom; Ancient history; Economic history; History","retraction":null,"screen_n_in":null,"score":{"opus":0.05159503446818506,"gpt":0.327198150431645,"spread":0.2756031159634599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005234026,0.0001199642,0.000454419,0.00008222891,0.0002657341,0.00002049244,0.00001919735,0.00001071691,0.00003472617],"category_scores_gemma":[0.00009522697,0.00007339101,0.0002333909,0.0001021326,0.00008971068,0.00004001303,0.00005993867,0.0001013652,0.000001833373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004419758,"about_ca_system_score_gemma":0.00006544626,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000355921,"about_ca_topic_score_gemma":0.000002554739,"domain_scores_codex":[0.9989826,0.0001524475,0.0003910806,0.0001223919,0.0002250821,0.0001264021],"domain_scores_gemma":[0.9990932,0.0002320715,0.0001608682,0.0001480596,0.0002843221,0.00008147114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002808966,0.00006156795,0.03799688,0.00004285074,0.001165589,0.00004337752,0.0009326317,0.0001920506,0.003579259,0.00002288255,0.946895,0.008787001],"study_design_scores_gemma":[0.001981875,0.00231261,0.01312437,0.00007008245,0.0005134722,0.002562713,0.001081552,0.00001729035,0.0004845973,0.000003849574,0.9777823,0.00006525355],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7290695,0.06412835,0.000231866,0.2050724,0.0004189437,0.0006604386,0.0001372689,0.00001605941,0.0002651724],"genre_scores_gemma":[0.9873049,0.003712495,0.006774042,0.0005233842,0.001160744,0.00001283457,0.000004567953,0.00003236772,0.0004746195],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2582355,"threshold_uncertainty_score":0.2992798,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2805115770","doi":"10.1002/ejhf.1236","title":"Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of Cardiology","year":2018,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":858,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Servier; GlaxoSmithKline; Deutsche Forschungsgemeinschaft; Astellas Pharma; Abiomed; HeartWare; European Society of Cardiology; Vifor Pharma; Pfizer; Thoratec Corporation; Sanofi; Respicardia; Abbott Vascular; St. Jude Medical; ZOLL Medical Corporation; AstraZeneca; Amgen","keywords":"Medicine; Heart failure; Cardiogenic shock; Intensive care medicine; Heart transplantation; Decompensation; Canadian Cardiovascular Society; Ejection fraction; Destination therapy; Quality of life (healthcare); Population; Inotrope; Internal medicine; Management of heart failure; Cardiology; Myocardial infarction; Angina","retraction":null,"screen_n_in":null,"score":{"opus":0.01715266276855578,"gpt":0.2513190046286951,"spread":0.2341663418601393,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004909,0.0005424796,0.002239896,0.000130034,0.0001268236,0.00003217847,0.0009679772,0.0002078975,0.0000754386],"category_scores_gemma":[0.0002040479,0.0003458539,0.002503849,0.00056828,0.0001529471,0.0002111014,0.0002677265,0.001331744,0.00005021864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003059661,"about_ca_system_score_gemma":0.0002322395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001505407,"about_ca_topic_score_gemma":0.000006276498,"domain_scores_codex":[0.9912372,0.004313783,0.002677284,0.0003281657,0.0009910748,0.0004525398],"domain_scores_gemma":[0.9956715,0.0002336654,0.002404895,0.0009154424,0.0006203015,0.0001541787],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000020478,0.00009790586,0.001803363,0.01411527,0.002672184,0.0000143874,0.0004826031,0.002194304,0.006702085,0.00004280365,0.9662264,0.005628225],"study_design_scores_gemma":[0.0004592649,0.0001992107,0.00099048,0.006469342,0.0006954251,0.0002169647,0.0001225666,0.00001307787,0.0004677562,0.00001092872,0.9900767,0.0002783055],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.009871936,0.964929,0.001701032,0.01271821,0.004749427,0.003872661,0.0008347315,0.0001970554,0.001125943],"genre_scores_gemma":[0.5797037,0.3485916,0.05938217,0.001357971,0.008052556,0.00004014179,0.0002159938,0.002047776,0.0006080199],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.6163374,"threshold_uncertainty_score":0.9998993,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099769151","doi":"10.1016/j.ejheart.2008.07.014","title":"State of the Art: Using Natriuretic Peptide Levels in Clinical Practice","year":2008,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":837,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Natriuretic peptide; Heart failure; Clinical Practice; Internal medicine; Cardiology; Intensive care medicine; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09969635210221914,"gpt":0.3914923341093954,"spread":0.2917959820071763,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003173048,0.0004098928,0.00232028,0.0003795481,0.00006457651,0.00002350508,0.0003104618,0.0000880282,0.00005999786],"category_scores_gemma":[0.001276673,0.0002308675,0.001489517,0.0005393281,0.0001681164,0.0001668877,0.0001667317,0.001713917,0.0001582545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001572119,"about_ca_system_score_gemma":0.0009038114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003144851,"about_ca_topic_score_gemma":0.000004652298,"domain_scores_codex":[0.9928673,0.002998301,0.0027782,0.0002754368,0.0007485961,0.0003321726],"domain_scores_gemma":[0.9965262,0.0005389281,0.001828336,0.0005730232,0.0003183838,0.0002151243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001721835,0.001116147,0.0008794133,0.006109595,0.001754821,0.01008047,0.0003779513,0.00002735006,0.000006543239,0.00001784895,0.5311849,0.4482727],"study_design_scores_gemma":[0.00124916,0.0005006544,0.0007233766,0.01782117,0.001453513,0.007770602,0.000033894,0.000002065174,0.000001169297,0.000001901095,0.9702792,0.0001632712],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004009448,0.9882514,0.00005821159,0.00871317,0.0005688401,0.001039476,0.00001073723,0.00001146485,0.0009457099],"genre_scores_gemma":[0.0002530297,0.9568594,0.0408117,0.0003690661,0.000556769,0.000001075867,0.000003359743,0.00009893394,0.001046648],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4481095,"threshold_uncertainty_score":0.9414502,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1484146179","doi":"10.1002/ejhf.260","title":"Clinical Picture and Risk Prediction of Short-Term Mortality in Cardiogenic Shock","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":792,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"Medicines Company; Aarne Koskelon Säätiö; Alere","keywords":"Cardiogenic shock; Medicine; Term (time); Shock (circulatory); Heart failure; Cardiology; Internal medicine; Intensive care medicine; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.03833665459214959,"gpt":0.269779536673242,"spread":0.2314428820810924,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002707785,0.0001250458,0.0004117489,0.00009279722,0.00001429068,0.00001554116,0.0001366788,0.0000623187,0.0000202116],"category_scores_gemma":[0.0001321602,0.0001070576,0.0001566103,0.0001100745,0.00003986397,0.0001679006,0.00003559013,0.0005838593,0.000008207143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002563586,"about_ca_system_score_gemma":0.00003126256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001427543,"about_ca_topic_score_gemma":0.000009507954,"domain_scores_codex":[0.9979721,0.000524328,0.0009419556,0.0001246218,0.0002907799,0.0001462054],"domain_scores_gemma":[0.999251,0.00004507095,0.0001263182,0.0002144245,0.0000982329,0.000264923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00001448266,0.00001931268,0.9934756,0.00003513665,0.0001164033,0.0001035312,0.0001454378,0.001677723,0.0004999028,0.000002862865,0.003287085,0.0006225778],"study_design_scores_gemma":[0.0006446766,0.00019917,0.9832425,0.00008341229,0.0001056084,0.0002038646,0.0001285787,0.0009155122,0.0001583002,0.00002765518,0.01419398,0.00009677566],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976695,0.0009568161,0.0005794993,0.00003950048,0.0004306444,0.0000752174,0.0000195875,0.0000259924,0.0002031955],"genre_scores_gemma":[0.9982455,0.00005834913,0.001321529,0.0000136083,0.0003284162,2.480478e-7,0.000002087385,0.00002757148,0.000002647483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0109069,"threshold_uncertainty_score":0.436568,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2944687799","doi":"10.1002/ejhf.1494","title":"Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations","year":2019,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":785,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Intracardiac injection; Natriuretic peptide; Atrial fibrillation; Myocardial infarction; Pulmonary embolism","retraction":null,"screen_n_in":null,"score":{"opus":0.08759918885117787,"gpt":0.3238729917196438,"spread":0.2362738028684659,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003799361,0.0004107473,0.002137183,0.0001236136,0.0001065556,0.00003134382,0.0003408669,0.0001446349,0.00006836278],"category_scores_gemma":[0.001312113,0.000217406,0.002208187,0.0004153693,0.0002289488,0.0001322557,0.0001607877,0.001299124,0.00007948033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002205477,"about_ca_system_score_gemma":0.00057347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003339176,"about_ca_topic_score_gemma":0.000002683589,"domain_scores_codex":[0.9911672,0.005453055,0.001830229,0.0002860883,0.0009245294,0.0003388532],"domain_scores_gemma":[0.9944106,0.001380665,0.002511501,0.0008549484,0.0007192997,0.000122946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003449946,0.0001451975,0.0019583,0.002727708,0.001612414,0.00003101497,0.000146804,0.00005644016,0.000125309,0.0002327226,0.9909388,0.001990726],"study_design_scores_gemma":[0.0007859381,0.0006678085,0.001598836,0.007736122,0.002505793,0.0002816411,0.0001149773,0.000003876205,0.00002413892,0.000001761174,0.9861354,0.0001437342],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002019736,0.6315118,0.0007973771,0.3488533,0.002359013,0.008929948,0.0004648334,0.00008134274,0.004982649],"genre_scores_gemma":[0.03389077,0.887582,0.06273684,0.002677982,0.003680549,0.00001903857,0.0001077362,0.0005163255,0.008788762],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3461753,"threshold_uncertainty_score":0.8865559,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2465883722","doi":"10.1002/ejhf.566","title":"European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":778,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"Boston Scientific Corporation; Boehringer Ingelheim; Sanofi; Bayer; AstraZeneca; ResMed; Eli Lilly and Company; Servier; Amgen","keywords":"Medicine; Heart failure; Observational study; Internal medicine; Epidemiology; Cardiology; Mortality rate; Clinical endpoint; Intensive care medicine; Clinical trial","retraction":null,"screen_n_in":null,"score":{"opus":0.02635033899928373,"gpt":0.2768683231665758,"spread":0.250517984167292,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001438931,0.000421814,0.001155513,0.00012849,0.0002140314,0.0000615942,0.0002860913,0.00009038921,0.00009039252],"category_scores_gemma":[0.0001651008,0.0002517065,0.00080575,0.0001752996,0.000482195,0.0002444697,0.0002569508,0.0004445568,0.0001104657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000603613,"about_ca_system_score_gemma":0.00008751327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004120229,"about_ca_topic_score_gemma":0.00001812321,"domain_scores_codex":[0.9967191,0.0007903273,0.0009415208,0.0004349721,0.000524101,0.0005899903],"domain_scores_gemma":[0.9979635,0.0001802292,0.0004470506,0.0006601085,0.0002996759,0.0004494111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001729496,0.00007937102,0.6227191,0.000138666,0.000654477,0.0003936862,0.0004650372,3.970288e-7,0.0067139,0.00005168091,0.3675015,0.001109216],"study_design_scores_gemma":[0.006104981,0.001103293,0.6520723,0.0008045796,0.0002940724,0.001126961,0.0007094292,3.568012e-7,0.0002926175,0.00001293944,0.3372274,0.0002510493],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.875508,0.0004256488,0.0009393092,0.121777,0.0003738865,0.0003733239,0.00003213898,0.00006748598,0.0005032687],"genre_scores_gemma":[0.9840001,0.000302069,0.01082584,0.0005791186,0.0006547283,0.000002034482,0.000007807987,0.0000825847,0.003545724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1211979,"threshold_uncertainty_score":0.9999935,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3031292493","doi":"10.1002/ejhf.1920","title":"Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":770,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ted Rogers Centre for Heart Research; Toronto General Hospital; University of Toronto; University Health Network; Sinai Health System; Mount Sinai Hospital","funders":"Cilag; National Heart, Lung, and Blood Institute; Pharmacyclics; Ipsen; National Cancer Institute; Servier; Astellas Pharma; Eisai; Daiichi-Sankyo; Deutsche Forschungsgemeinschaft; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Sanofi; Abiomed; Pfizer; Incyte; Intas Pharmaceuticals; CTI Biopharma; Fondation Leducq; Novo Nordisk; MyoKardia; Accuray; Amicus Therapeutics; Regeneron Pharmaceuticals; Boston Scientific Corporation; AstraZeneca; Barts Charity; Karyopharm Therapeutics; Alere; Audentes Therapeutics; Amgen; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Celgene; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Cancer; Cardiotoxicity; Oncology; Trastuzumab; Risk assessment; Heart failure; Intensive care medicine; Breast cancer; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01810643388680444,"gpt":0.291954862261243,"spread":0.2738484283744386,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007452266,0.0002750136,0.001131902,0.0000549084,0.0001728394,0.00004236971,0.0003695462,0.0001092469,0.00001001652],"category_scores_gemma":[0.0002851532,0.0001494975,0.0008269752,0.0006589008,0.0001472931,0.0001865472,0.0001811938,0.001200635,3.24418e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00144778,"about_ca_system_score_gemma":0.001110035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007760567,"about_ca_topic_score_gemma":0.0009877306,"domain_scores_codex":[0.988429,0.00869113,0.001084238,0.000376905,0.001174801,0.0002439171],"domain_scores_gemma":[0.9965939,0.0005253809,0.001327905,0.0004377275,0.001008281,0.0001067938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004623849,0.0002277013,0.8705326,0.00003947725,0.006332282,0.000007168038,0.02118723,0.02499526,0.04815552,0.000001921261,0.02440265,0.003655842],"study_design_scores_gemma":[0.008480371,0.001648053,0.9219007,0.0003051827,0.001211845,0.00001239491,0.02216912,0.000149676,0.002851124,0.000005016007,0.0411128,0.0001536661],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9242976,0.0005975621,0.001054327,0.07135078,0.0003103652,0.002017495,0.0003147129,0.000006549865,0.00005063221],"genre_scores_gemma":[0.9940104,0.0009303112,0.002753034,0.001476939,0.0007259018,0.00003713329,0.00002099092,0.00004102347,0.000004291538],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06987384,"threshold_uncertainty_score":0.6096329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2945994263","doi":"10.1002/ejhf.1531","title":"Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":608,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Intensive care medicine; Guideline; MitraClip; Clinical trial; Rivaroxaban; Atrial fibrillation; Evidence-based practice; Canadian Cardiovascular Society; MEDLINE; Consensus conference; Cardiac resynchronization therapy; Management of heart failure; Position paper; Evidence-based medicine; Systematic review; Cardiology; Internal medicine; Alternative medicine; Warfarin; Ejection fraction; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01604834507969072,"gpt":0.3068379919983394,"spread":0.2907896469186487,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00561966,0.000340162,0.0009624435,0.0001097445,0.00015244,0.00003255022,0.0002994271,0.00009567825,0.00003974546],"category_scores_gemma":[0.0003984292,0.000205405,0.000711505,0.0002921281,0.000202388,0.0001955937,0.0002409192,0.0007262892,0.00001726561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007955378,"about_ca_system_score_gemma":0.0001533652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001644645,"about_ca_topic_score_gemma":0.00001222669,"domain_scores_codex":[0.9928007,0.003600641,0.001783213,0.0004360103,0.001010252,0.0003691443],"domain_scores_gemma":[0.9958897,0.000354822,0.00212561,0.0007539681,0.0006912844,0.000184636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004162279,0.0004270851,0.1503974,0.0002804367,0.001462245,0.0001020434,0.0008329114,0.0001265792,0.0135882,0.00002688779,0.8314457,0.0008943171],"study_design_scores_gemma":[0.003147263,0.001284764,0.06609205,0.0009061064,0.000508379,0.0008872057,0.002603393,0.00001182957,0.001896359,0.000003634507,0.9224854,0.0001735881],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7723954,0.0007887558,0.00001852269,0.2226697,0.0006437994,0.001567246,0.00002013274,0.00003195291,0.001864527],"genre_scores_gemma":[0.9599847,0.00023251,0.03409936,0.004762828,0.0004389682,0.000002725802,0.000008199761,0.00007975975,0.0003909857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2179068,"threshold_uncertainty_score":0.8376173,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2542456927","doi":"10.1002/ejhf.657","title":"Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":564,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Hospital","funders":"Sanofi France; Pfizer; Daiichi-Sankyo; Novo Nordisk; Steno Diabetes Center Copenhagen; Bayer; Novartis","keywords":"Medicine; Liraglutide; Heart failure; Placebo; Diabetes mellitus; Internal medicine; Glucagon-like peptide-1; Cardiology; Glucagon; Double blind; Endocrinology; Insulin; Type 2 diabetes","retraction":null,"screen_n_in":null,"score":{"opus":0.006214557916760957,"gpt":0.2204485825725055,"spread":0.2142340246557446,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00185073,0.0004115015,0.001349563,0.0005168591,0.00008023794,0.00004826941,0.0001119969,0.00006243124,0.0001149612],"category_scores_gemma":[0.000166696,0.0002194389,0.0003330901,0.0002030824,0.00009422629,0.0003058291,0.0000538176,0.0003072923,0.00004552823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001695167,"about_ca_system_score_gemma":0.00008962599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004585188,"about_ca_topic_score_gemma":0.00002575804,"domain_scores_codex":[0.9966967,0.0009281502,0.0008784079,0.000358498,0.000641424,0.0004968708],"domain_scores_gemma":[0.9982464,0.0003703391,0.0005817501,0.0003120425,0.000222613,0.0002669062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7737974,0.0007166746,0.2174011,0.0001806075,0.0009958685,0.00006208983,0.00005380461,0.00007110687,0.0007358486,0.000002308023,0.005075233,0.0009079661],"study_design_scores_gemma":[0.9361863,0.02398095,0.02028802,0.001723299,0.001347609,0.00001109877,0.0000343099,0.00002773693,0.001406814,9.984984e-7,0.01477105,0.0002218376],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932829,0.0005532868,0.00002816561,0.001140355,0.0002534183,0.004615142,0.000005236937,0.00002227317,0.00009928592],"genre_scores_gemma":[0.9987835,0.00003296524,0.0003576156,0.00009958383,0.0002572433,0.00003351599,0.00001751496,0.00006172897,0.0003563118],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1971131,"threshold_uncertainty_score":0.894846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3029617361","doi":"10.1002/ejhf.1922","title":"Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology","year":2020,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":489,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Respicardia; Abbott Vascular; Servier; Pfizer; Vifor Pharma; Impulse Dynamics; HeartWare; Boston Scientific Corporation; Eisai; Sanofi; MyoKardia; Bristol-Myers Squibb; AstraZeneca; Amgen","keywords":"Medicine; Cardiogenic shock; Intensive care medicine; Heart failure; Clinical trial; Psychological intervention; Epidemiology; Harm; Translational research; Cardiology; Internal medicine; Pathology; Myocardial infarction; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.03431570527179768,"gpt":0.2601521100798038,"spread":0.2258364048080061,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00456319,0.0003704112,0.002531031,0.00005114792,0.00005901609,0.000006903831,0.0005466112,0.0001439055,0.0000134679],"category_scores_gemma":[0.00009850401,0.0002286466,0.001560776,0.0002143549,0.00012045,0.00007394771,0.0002843899,0.0008624832,0.00001028546],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000112171,"about_ca_system_score_gemma":0.00008241367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003836351,"about_ca_topic_score_gemma":8.751657e-7,"domain_scores_codex":[0.9893844,0.00752214,0.00224996,0.0002802293,0.0003150339,0.0002482807],"domain_scores_gemma":[0.9967642,0.0006435712,0.001838505,0.0004899318,0.0001581721,0.0001056115],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007219074,0.00008772171,0.01362556,0.027239,0.02414173,0.0002197778,0.0009528829,0.002666658,0.002524941,0.0001801925,0.8794988,0.04879052],"study_design_scores_gemma":[0.0004031731,0.0001608511,0.005342764,0.003468733,0.001202808,0.00006971023,0.0002368523,0.00002337873,0.00001778066,0.00005227036,0.9888304,0.00019122],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001558485,0.9932119,0.0006232727,0.002788221,0.0004678608,0.0007402367,0.0004208388,0.00002429505,0.0001649143],"genre_scores_gemma":[0.2203038,0.770856,0.006891953,0.0004908595,0.001071199,0.000008694054,0.000138389,0.0002234239,0.00001569261],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2223559,"threshold_uncertainty_score":0.9323937,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2098418963","doi":"10.1093/eurjhf/hft052","title":"Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF)","year":2013,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":452,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Novartis Pharma","keywords":"Enalapril; Medicine; Heart failure; Neprilysin; Sacubitril; Internal medicine; Cardiology; Valsartan; Renin–angiotensin system; Natriuretic peptide; ACE inhibitor; Natriuresis; Ejection fraction; Pharmacology; Angiotensin-converting enzyme; Endocrinology; Blood pressure; Chemistry; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.02867095127254463,"gpt":0.2881548921477827,"spread":0.2594839408752381,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007873536,0.0003113714,0.0007928228,0.0002613432,0.00008792934,0.00005555727,0.000041351,0.00005892634,0.00001059754],"category_scores_gemma":[0.0001445355,0.0001998004,0.00008969352,0.0003823679,0.0001331473,0.0003954241,0.00005624177,0.0002528369,0.000002645148],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002961502,"about_ca_system_score_gemma":0.0001650229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002683283,"about_ca_topic_score_gemma":0.0005995443,"domain_scores_codex":[0.9975342,0.0005714934,0.0007237372,0.0003860785,0.0004826582,0.0003018968],"domain_scores_gemma":[0.9986517,0.0001055301,0.0003803157,0.0002257337,0.0003707518,0.0002659443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03832094,0.001840801,0.8997386,0.0002076264,0.0004760222,0.00005940672,0.003911387,0.003159037,0.02531752,0.00007884784,0.02636309,0.0005266846],"study_design_scores_gemma":[0.03045643,0.02361251,0.9323764,0.001523349,0.0001603266,0.0001543647,0.0003640452,0.000422655,0.01003133,0.00003911101,0.0006010996,0.0002584027],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9780522,0.00004344142,0.000396476,0.0170577,0.00003895129,0.004374322,0.00002640513,0.000009025196,0.000001485608],"genre_scores_gemma":[0.9814897,0.000001517188,0.01804506,0.0002345447,0.0001543518,0.00002442987,0.00001671193,0.00002941579,0.000004320471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03263774,"threshold_uncertainty_score":0.8147625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2790275265","doi":"10.1002/ejhf.1149","title":"Heart Failure with Mid-Range Ejection Fraction in CHARM: Characteristics, Outcomes and Effect of Candesartan Across the Entire Ejection Fraction Spectrum","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":425,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Vetenskapsrådet; Stockholms Läns Landsting; AstraZeneca","keywords":"Candesartan; Medicine; Ejection fraction; Heart failure; Internal medicine; Hazard ratio; Cardiology; Incidence (geometry); Confidence interval; Placebo; Angiotensin II; Blood pressure","retraction":null,"screen_n_in":null,"score":{"opus":0.009659056238576194,"gpt":0.2672200015461359,"spread":0.2575609453075597,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001594649,0.0002902353,0.0006569372,0.0002590514,0.0002345125,0.00007277941,0.00007486838,0.00006841686,0.0001234015],"category_scores_gemma":[0.0001076465,0.0001741987,0.0001651545,0.0003120706,0.0001711685,0.0003778439,0.00003740139,0.0005729211,0.00005155706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001572584,"about_ca_system_score_gemma":0.00004157939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001084193,"about_ca_topic_score_gemma":0.0003469698,"domain_scores_codex":[0.9977535,0.0005747921,0.0006097011,0.0002678948,0.0004592884,0.0003348484],"domain_scores_gemma":[0.9988438,0.0001139648,0.0004252361,0.000283962,0.0001871334,0.0001458478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001320057,0.0001646684,0.9750813,0.0001265218,0.0002244609,0.00009869054,0.0004088515,0.00000166565,0.00690714,0.000003644469,0.01414006,0.001522961],"study_design_scores_gemma":[0.003863213,0.004479651,0.8031596,0.0004485938,0.0002593573,0.0005805595,0.0007748951,0.00002309475,0.005254851,0.000002946472,0.1809969,0.0001563506],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9720368,0.00007895241,0.000215423,0.02652138,0.0004196838,0.0005921077,0.000005638035,0.0000319994,0.00009802095],"genre_scores_gemma":[0.9976246,0.00004155755,0.001011864,0.0002501605,0.000827953,0.000005188839,0.000009566528,0.00004715822,0.0001819274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1719217,"threshold_uncertainty_score":0.7103618,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2081438731","doi":"10.1093/eurjhf/hfn031","title":"Liver Function Abnormalities and Outcome in Patients with Chronic Heart Failure: Data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program","year":2009,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Candesartan; Bilirubin; Cardiology; Liver function; Liver function tests; Blood pressure","retraction":null,"screen_n_in":null,"score":{"opus":0.0427266887938246,"gpt":0.3088556145985037,"spread":0.2661289258046792,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001784694,0.0002874216,0.000664535,0.0002622518,0.00007366772,0.00007129632,0.0001468507,0.00005993495,0.00005633842],"category_scores_gemma":[0.00005054853,0.0001946569,0.00006641774,0.0003433796,0.0001437017,0.0006278662,0.0001087442,0.0006720701,0.000002969161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002027983,"about_ca_system_score_gemma":0.0001538505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009001322,"about_ca_topic_score_gemma":0.00450027,"domain_scores_codex":[0.9971088,0.0006551361,0.0009147412,0.0004025933,0.0005660463,0.0003527485],"domain_scores_gemma":[0.9988561,0.0000624876,0.0002620565,0.0005391421,0.0001197361,0.0001604223],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002940834,0.0006300206,0.9792706,0.00006968096,0.00008194245,0.00006043416,0.0002691868,0.000032583,0.0002402569,0.00001676763,0.01799086,0.001043588],"study_design_scores_gemma":[0.005278166,0.002438003,0.9447042,0.0004702836,0.0001430641,0.00006164201,0.0005129554,0.0001069689,0.0000273241,0.00001177306,0.04608462,0.000160992],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713765,0.0004350245,0.00002154074,0.02695146,0.00008905388,0.001064886,0.0000238452,0.00001860266,0.00001911519],"genre_scores_gemma":[0.9901019,0.00005611489,0.009258739,0.000257044,0.0001928797,0.000005971891,0.00008375626,0.00002462367,0.00001896775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03456639,"threshold_uncertainty_score":0.793788,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3021974182","doi":"10.1002/ejhf.289","title":"Recommendations on Pre-Hospital &amp; Early Hospital Management of Acute Heart Failure: A Consensus Paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine","year":2015,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":409,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"Respicardia; Abbott Vascular; Servier; Schweizerische Herzstiftung; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; BG Medicine; Medicines Company; Teva Pharmaceutical Industries; Universitätsspital Basel; Alere; Sanofi; Eli Lilly and Company; Amgen; Vifor Pharma; Pfizer; National Science Foundation","keywords":"Medicine; Heart failure; Intensive care medicine; Medical emergency; Acute care; Health care; Emergency medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04483851991829828,"gpt":0.3233714303596332,"spread":0.2785329104413349,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01452959,0.0009504826,0.003549673,0.0001166028,0.0003654548,0.00001083479,0.001218706,0.0002668027,0.0002870964],"category_scores_gemma":[0.0004026523,0.0004382478,0.003968238,0.0009897994,0.001496884,0.0001538054,0.0007984882,0.002377463,0.00001808161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001863224,"about_ca_system_score_gemma":0.0002241231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001022145,"about_ca_topic_score_gemma":0.00001389339,"domain_scores_codex":[0.9848843,0.007316448,0.004623054,0.0006681852,0.001899569,0.000608393],"domain_scores_gemma":[0.9903705,0.0009876506,0.005474361,0.001601016,0.001311592,0.000254901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008395852,0.0001939816,0.00338985,0.001901005,0.01020732,0.000003711786,0.006620082,0.00000706674,0.0001794494,0.00006881504,0.9746947,0.002650119],"study_design_scores_gemma":[0.004150175,0.00143687,0.01135467,0.009155878,0.01047791,0.00004234616,0.004981505,0.000002911274,0.000007476265,0.00004718258,0.9580212,0.0003218417],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.007084928,0.3801332,0.0001927222,0.6005836,0.002987664,0.006172183,0.0007604612,0.00006240147,0.002022867],"genre_scores_gemma":[0.01970553,0.965209,0.008648986,0.0007121338,0.003144762,0.00003077165,0.0002731197,0.0003240918,0.001951585],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.5998714,"threshold_uncertainty_score":0.9999241,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2609879055","doi":"10.1002/ejhf.823","title":"Effects of Ferric Carboxymaltose on Hospitalisations and Mortality Rates in Iron-Deficient Heart Failure Patients: An Individual Patient data Meta-Analysis","year":2017,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":402,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Janssen Biotech; Abbott Vascular; Servier; Janssen Canada; Relypsa; Vifor Pharma; Novartis; Bayer","keywords":"Medicine; Heart failure; Internal medicine; Confidence interval; Placebo; Meta-analysis; Mortality rate; Iron deficiency; Randomized controlled trial; Quality of life (healthcare); Pediatrics; Anemia","retraction":null,"screen_n_in":null,"score":{"opus":0.1382224270607655,"gpt":0.3801596701196882,"spread":0.2419372430589227,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001618995,0.0006569725,0.004458292,0.0008307904,0.0001594058,0.0001138558,0.0005629501,0.0001405256,0.00006791604],"category_scores_gemma":[0.0004337456,0.0004197487,0.001537552,0.0004450512,0.0002036901,0.0002610188,0.0003155844,0.000925327,0.00001403329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008938049,"about_ca_system_score_gemma":0.0002657963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005037606,"about_ca_topic_score_gemma":0.00005040448,"domain_scores_codex":[0.9941759,0.001992899,0.001789068,0.0006935,0.0009933296,0.0003552737],"domain_scores_gemma":[0.9956089,0.0002763566,0.001775939,0.001662601,0.0002726143,0.0004036432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004285297,0.03273148,0.1212466,0.06366262,0.4599795,0.006047665,0.007085403,0.0002280139,0.00003008562,0.0001122295,0.1311992,0.1772486],"study_design_scores_gemma":[0.002015499,0.004556793,0.03585257,0.003974861,0.3086855,0.0001532275,0.0002144289,0.000003647519,0.00001094421,0.000002177406,0.6440098,0.0005205696],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.07535561,0.9211504,0.000002307814,0.001295542,0.0001738516,0.001365407,0.0005886125,0.00001405487,0.00005424854],"genre_scores_gemma":[0.2734585,0.7135876,0.008777719,0.000421657,0.0004738807,0.00003846326,0.002865255,0.0002851473,0.00009171737],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5128106,"threshold_uncertainty_score":0.9998254,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1553852627","doi":"10.1093/eurjhf/hfr039","title":"Which Components of Heart Failure Programmes are Effective? A Systematic Review and Meta-Analysis of the Outcomes of Structured Telephone Support or Telemonitoring as the Primary Component of Chronic Heart Failure Management in 8323 Patients: Abridged Cochrane Review","year":2011,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":382,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Heart failure; Meta-analysis; Component (thermodynamics); Management of heart failure; Intensive care medicine; Systematic review; MEDLINE; Cardiology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03367189780212992,"gpt":0.3125810653389437,"spread":0.2789091675368138,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.005209611,0.001163331,0.01718547,0.0009631278,0.0001087828,0.00002901207,0.0008963834,0.0001552619,0.0002501899],"category_scores_gemma":[0.0004837891,0.0005436965,0.004547365,0.002449407,0.0003039179,0.0001724812,0.0005408609,0.001069861,0.0000106163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002701663,"about_ca_system_score_gemma":0.0002657481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004678308,"about_ca_topic_score_gemma":0.0001047506,"domain_scores_codex":[0.9863496,0.004760682,0.005800525,0.0006701178,0.001837458,0.0005815979],"domain_scores_gemma":[0.9901906,0.000559589,0.005969983,0.001899843,0.001120698,0.00025931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00009229327,0.001026514,0.002511021,0.8729873,0.1084395,0.00005690085,0.0001518461,0.000002824067,0.00001509894,0.000008935044,0.01354994,0.001157763],"study_design_scores_gemma":[0.001857415,0.001258123,0.01479296,0.2589636,0.4674783,0.000268296,0.0001192814,4.322224e-7,0.00002191226,9.049558e-7,0.2548525,0.0003862964],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009664685,0.975698,0.000004678445,0.008275899,0.0001341307,0.01474379,0.0001362114,0.00001749827,0.00002334086],"genre_scores_gemma":[0.01309873,0.98083,0.004735613,0.0005363644,0.00006380495,0.0002295873,0.000152173,0.0001751917,0.0001785179],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6140237,"threshold_uncertainty_score":0.9997014,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971240641","doi":"10.1016/s1388-9842(03)00163-6","title":"Adverse Mortality Effect of Central Sympathetic Inhibition with Sustained-Release Moxonidine in Patients with Heart Failure (MOXCON)","year":2003,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Moxonidine; Medicine; Placebo; Heart failure; Adverse effect; Anesthesia; Internal medicine; Randomized controlled trial; Cardiology; Agonist; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.003769685408574886,"gpt":0.2000382296741074,"spread":0.1962685442655326,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001775621,0.0002989378,0.0008216777,0.0002307612,0.00006153017,0.00001862803,0.00007116828,0.00005938169,0.0001693321],"category_scores_gemma":[0.0002732872,0.000197679,0.0002051924,0.0003353212,0.0001511171,0.0002698245,0.00001823669,0.00064925,0.00001617569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001560656,"about_ca_system_score_gemma":0.0003760371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001328436,"about_ca_topic_score_gemma":0.00002194479,"domain_scores_codex":[0.9966755,0.001278648,0.0008409274,0.0002742797,0.0004721661,0.0004584844],"domain_scores_gemma":[0.9984937,0.0001134681,0.0003203474,0.0003578308,0.0003438623,0.0003707672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001395713,0.000783703,0.9896594,0.0003144706,0.0001304386,0.0003621759,0.0003291239,0.0007772878,0.00473919,0.0000443912,0.001273862,0.0001902573],"study_design_scores_gemma":[0.02872997,0.01269719,0.9126915,0.001615104,0.000421117,0.0003719013,0.000523996,0.00005949613,0.00821191,0.000008155357,0.03428278,0.0003869058],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960521,0.00003531333,0.0001012048,0.002909699,0.00006646985,0.000703283,0.00001246816,0.00001714134,0.0001022582],"genre_scores_gemma":[0.9980023,0.00000174204,0.001631177,0.000193054,0.0000803933,0.000002184217,0.00001216885,0.00004559909,0.00003138143],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07696791,"threshold_uncertainty_score":0.8061116,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2590357760","doi":"10.1002/ejhf.765","title":"Comparative Effectiveness of Transitional Care Services in Patients Discharged from the Hospital with Heart Failure: A Systematic Review and Network Meta-Analysis","year":2017,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Impact; Public Health Ontario; University of Toronto; McMaster University; Population Health Research Institute","funders":"National Institute for Health and Care Research; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Medicine; Meta-analysis; Confidence interval; Relative risk; Randomized controlled trial; CINAHL; Transitional care; Heart failure; Emergency medicine; MEDLINE; Internal medicine; Physical therapy; Health care; Psychological intervention; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.04343051874592506,"gpt":0.3117480225815273,"spread":0.2683175038356023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002095251,0.0006058801,0.01002001,0.0002139629,0.0001546954,0.00008016653,0.0003273678,0.00006713931,0.00006291365],"category_scores_gemma":[0.00003891237,0.0002807141,0.002250497,0.0004547959,0.0001184783,0.0001922442,0.00007708236,0.0006134667,0.00001667059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007110744,"about_ca_system_score_gemma":0.000131425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002058805,"about_ca_topic_score_gemma":0.00008792654,"domain_scores_codex":[0.9926701,0.004482157,0.001497842,0.0003930175,0.0006900736,0.0002668308],"domain_scores_gemma":[0.9966191,0.0005133431,0.001530769,0.0007093514,0.0004543799,0.0001730715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001632911,0.0004200839,0.003479565,0.7864938,0.202011,0.0001653806,0.001037058,0.0000160793,1.302651e-7,0.000009488637,0.006057279,0.000146862],"study_design_scores_gemma":[0.00140372,0.0008938927,0.005070866,0.2476959,0.5714298,0.00004550285,0.0002141081,4.257616e-7,1.919798e-7,0.000001187564,0.1729793,0.0002651251],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002820607,0.9925424,0.00001788255,0.002894037,0.00004100557,0.004054438,0.0001459391,0.000007308272,0.00001488036],"genre_scores_gemma":[0.04986797,0.940982,0.007073951,0.0004495017,0.0002968911,0.0001938381,0.0009428152,0.0001493815,0.00004362686],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5387979,"threshold_uncertainty_score":0.9999645,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2936316583","doi":"10.1002/ejhf.1461","title":"Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada); University Hospital Foundation","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Ejection fraction; Etiology; Intensive care medicine; Cardiomyopathy","retraction":null,"screen_n_in":null,"score":{"opus":0.007926918952933378,"gpt":0.2180890254392268,"spread":0.2101621064862934,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00469205,0.0003171166,0.001278622,0.0001023935,0.0001561997,0.00003273768,0.0003309625,0.0001206556,0.00004809567],"category_scores_gemma":[0.0003329623,0.0001961751,0.00149656,0.0004740777,0.0002003434,0.0002149424,0.0002466977,0.001179822,0.0000579314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001681235,"about_ca_system_score_gemma":0.0001625612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004566563,"about_ca_topic_score_gemma":0.00003490695,"domain_scores_codex":[0.9939137,0.003424669,0.001110536,0.0003190171,0.0008351979,0.0003968916],"domain_scores_gemma":[0.9974307,0.0004349476,0.0007133365,0.0006870881,0.0006289581,0.0001048997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0001575703,0.00005490108,0.4138281,0.00009280314,0.0006245117,0.00003120794,0.002319509,0.0002842362,0.09377944,0.00001599107,0.4886921,0.0001196293],"study_design_scores_gemma":[0.002148305,0.0003805689,0.5303237,0.000737424,0.0003116046,0.0004698946,0.003952721,0.000003528256,0.001105266,0.00001815421,0.4603985,0.0001502854],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8888425,0.001636257,0.00007387497,0.106519,0.0007286801,0.0006302654,0.00009609761,0.00002469928,0.001448651],"genre_scores_gemma":[0.9939348,0.00008731724,0.002393926,0.001943817,0.001405081,0.000002010284,0.00001221554,0.00006374348,0.0001570686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1164956,"threshold_uncertainty_score":0.7999788,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2921909893","doi":"10.1002/ejhf.1436","title":"The Role of Ventricular–Arterial Coupling in Cardiac Disease and Heart Failure: Assessment, Clinical Implications and Therapeutic Interventions. A Consensus Document of the European Society of Cardiology Working Group on Aorta &amp; Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Heart failure; valvular heart disease; Pathophysiology; Compliance (psychology); Cardiac function curve","retraction":null,"screen_n_in":null,"score":{"opus":0.01210325077283122,"gpt":0.2710647052507983,"spread":0.2589614544779671,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00748284,0.0002363086,0.001071017,0.0001121023,0.0001524253,0.00005226763,0.0001421077,0.00006148668,0.000005887938],"category_scores_gemma":[0.0003114649,0.0001652008,0.002231224,0.0002449664,0.000213997,0.00006961179,0.0001513496,0.0005816435,0.000001241538],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001537916,"about_ca_system_score_gemma":0.000109552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001937631,"about_ca_topic_score_gemma":0.000006833289,"domain_scores_codex":[0.9932852,0.004159808,0.001272552,0.0003343101,0.0006922681,0.0002558885],"domain_scores_gemma":[0.9974836,0.0003770416,0.0009863949,0.000579063,0.0003970261,0.0001769436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001025865,0.0001061846,0.9902442,0.0001328592,0.002831012,0.000004029495,0.0001236053,0.0007108974,0.00269147,0.00004277634,0.002141799,0.0008686515],"study_design_scores_gemma":[0.002625793,0.0001892041,0.8709812,0.0004997373,0.0015459,0.00003929583,0.0005288829,0.00006232467,0.0000239111,0.00001925076,0.1233642,0.0001203396],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833317,0.01116246,0.0001899746,0.004165019,0.0003812137,0.000677451,0.00004456143,0.00001143927,0.00003620659],"genre_scores_gemma":[0.998181,0.0008048569,0.0005617913,0.00006069365,0.0003110768,0.000002589696,0.00001754648,0.00004568914,0.00001471303],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1212224,"threshold_uncertainty_score":0.6736695,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2947972779","doi":"10.1002/ejhf.1498","title":"Initiation of Sacubitril/Valsartan in Haemodynamically Stabilised Heart Failure Patients in Hospital or Early After Discharge: Primary Results of the Randomised TRANSITION Study","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":352,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"National Institute for Health and Care Research; Novartis","keywords":"Medicine; Sacubitril, Valsartan; Heart failure; Valsartan; Sacubitril; Cardiology; Internal medicine; Ejection fraction","retraction":null,"screen_n_in":null,"score":{"opus":0.006039076943491355,"gpt":0.2205666199185383,"spread":0.214527542975047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001555267,0.0002448776,0.001002434,0.0003602997,0.00002588537,0.00002001886,0.0001558923,0.00005644104,0.00008761744],"category_scores_gemma":[0.0001944227,0.0001512725,0.0002886393,0.0004705171,0.00006417424,0.0003482126,0.00005604174,0.0004495686,0.00001415198],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001211014,"about_ca_system_score_gemma":0.000152298,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002640404,"about_ca_topic_score_gemma":0.0001295657,"domain_scores_codex":[0.9960632,0.001112106,0.001536867,0.0002658415,0.0007550432,0.0002669214],"domain_scores_gemma":[0.9985805,0.0001418924,0.0004761291,0.0003932277,0.0002984843,0.0001097958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04361087,0.007262093,0.9194508,0.0003884131,0.0002261947,0.0001923799,0.01266077,0.0001461461,0.009481746,0.000003309869,0.006314887,0.0002624145],"study_design_scores_gemma":[0.06910665,0.005265511,0.9211046,0.0008738456,0.0001466697,0.00001030923,0.001078609,0.00002202279,0.000424576,0.000003937468,0.001817157,0.00014613],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852317,0.00002888808,0.00001500364,0.01174984,0.0001462809,0.002713121,0.00002937082,0.00000821132,0.00007757845],"genre_scores_gemma":[0.9977843,0.000005336767,0.001871215,0.0001515757,0.00005706004,0.000007449551,0.00002070379,0.00003875341,0.00006363639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02549578,"threshold_uncertainty_score":0.6168715,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116480815","doi":"10.1002/ejhf.151","title":"Effects of Person-Centred and Integrated Chronic Heart Failure and Palliative Home Care. PREFER: A Randomized Controlled Study","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Sveriges Kommuner och Landsting; Riksförbundet HjärtLung","keywords":"Medicine; Quality of life (healthcare); Heart failure; Nausea; Randomized controlled trial; Palliative care; Internal medicine; Physical therapy; Pediatrics; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.008603776320727785,"gpt":0.2287235967737326,"spread":0.2201198204530048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001580954,0.000395353,0.002510352,0.0003332115,0.000107437,0.00006502582,0.0000954241,0.00005376153,0.00005620034],"category_scores_gemma":[0.0005603001,0.0002446916,0.0004244797,0.0001768373,0.0001979373,0.0001376869,0.00006564691,0.0004420449,0.0000137438],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008374805,"about_ca_system_score_gemma":0.0001139389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000016992,"about_ca_topic_score_gemma":0.0000265936,"domain_scores_codex":[0.9955439,0.002458892,0.000861273,0.0003215818,0.0004803152,0.0003340228],"domain_scores_gemma":[0.9979154,0.0006697244,0.0004440171,0.0002398648,0.0003889557,0.000342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4663319,0.006215374,0.1305674,0.006498398,0.02405738,0.002758791,0.07377955,0.00005462239,0.05486895,0.0004221487,0.2234334,0.01101207],"study_design_scores_gemma":[0.8593601,0.01054147,0.02813712,0.001729053,0.00378794,0.0002125438,0.008762335,0.0001576136,0.0009064006,0.00000910611,0.08601274,0.0003835894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9756563,0.006478883,0.0001980452,0.01336014,0.0001561518,0.003986945,0.000002944649,0.00004056564,0.0001200788],"genre_scores_gemma":[0.9937565,0.0001411582,0.005386039,0.0001821984,0.0002385217,0.00001995005,0.000005136527,0.00005114628,0.0002193915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3930282,"threshold_uncertainty_score":0.9978234,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2058490784","doi":"10.1016/j.ejheart.2005.08.005","title":"Effectiveness of Comprehensive Disease Management Programmes in Improving Clinical Outcomes in Heart Failure Patients. A Meta-Analysis","year":2005,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":346,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Heart failure; Meta-analysis; Psychological intervention; Disease management; Internal medicine; Population; Randomized controlled trial; Clinical trial; MEDLINE; Intensive care medicine; Disease; Emergency medicine; Physical therapy; Environmental health; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.0718032093779349,"gpt":0.3751198080827113,"spread":0.3033165987047765,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004035394,0.0008999893,0.009171648,0.002324965,0.00004823037,0.00006174087,0.0003933355,0.0001488865,0.0001256051],"category_scores_gemma":[0.0001769448,0.0005913203,0.007855847,0.00148118,0.0001404583,0.0002107131,0.0003098387,0.00123735,0.00006167485],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000262578,"about_ca_system_score_gemma":0.0002250021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000186654,"about_ca_topic_score_gemma":0.00005156589,"domain_scores_codex":[0.9887002,0.005143892,0.003777129,0.0007755928,0.0009849138,0.0006182867],"domain_scores_gemma":[0.9961069,0.000715961,0.001396303,0.0008920379,0.0003616631,0.0005271195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001333237,0.01236379,0.1945704,0.06813382,0.3504352,0.006633044,0.0001839958,0.0001639362,8.17225e-7,0.00009158152,0.0188124,0.3472778],"study_design_scores_gemma":[0.003140812,0.0007279348,0.06210989,0.003435452,0.1695056,0.00002121174,0.00006497477,0.000002051231,1.78394e-7,0.000001650876,0.7606561,0.0003341234],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002829075,0.9864026,0.00006317931,0.004686405,0.0002149765,0.005650024,0.00006096147,0.00004106583,0.00005165614],"genre_scores_gemma":[0.03735578,0.8602045,0.09942448,0.0006353561,0.0004935458,0.0002960938,0.000496909,0.0005076345,0.0005856617],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7418437,"threshold_uncertainty_score":0.9996538,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127749568","doi":"10.1002/ejhf.327","title":"Characterization of Subgroups of Heart Failure Patients with Preserved Ejection Fraction with Possible Implications for Prognosis and Treatment Response","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":282,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"National Heart, Lung, and Blood Institute; Sanofi; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Irbesartan; Heart failure; Internal medicine; Cardiology; Heart failure with preserved ejection fraction; Candesartan; Ejection fraction; Atrial fibrillation; Subgroup analysis; Placebo; Diabetes mellitus; Blood pressure; Angiotensin II; Meta-analysis; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.02019735581278551,"gpt":0.2414163846807837,"spread":0.2212190288679982,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005512103,0.0001280195,0.0003615282,0.0002056378,0.00006131097,0.00001795703,0.00003089414,0.00003468239,0.000006909023],"category_scores_gemma":[0.00008557164,0.00008050435,0.0001431813,0.0002141275,0.00005253747,0.0002374459,0.000008912462,0.0001030493,0.000001009021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007195349,"about_ca_system_score_gemma":0.0001364058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008323875,"about_ca_topic_score_gemma":0.000009284129,"domain_scores_codex":[0.9988356,0.0002912027,0.0003679372,0.0001399432,0.0002589159,0.0001063586],"domain_scores_gemma":[0.9982303,0.00004301379,0.0003658958,0.0001865258,0.001012423,0.0001618899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008379826,0.0003880017,0.9409442,0.00004660033,0.0003031355,0.000001763515,0.0002167815,0.00002504117,0.0477118,0.000002107977,0.001522499,0.0004582684],"study_design_scores_gemma":[0.005529428,0.00812639,0.9235252,0.0001787638,0.0003184965,0.000129468,0.0002821573,0.000006576524,0.01025485,9.020625e-7,0.05157267,0.00007515193],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931408,0.00003710036,0.001987439,0.004090212,0.00005240175,0.0006418065,0.00002910812,0.00001307853,0.000008042359],"genre_scores_gemma":[0.9933504,0.00001343206,0.006361593,0.00002750382,0.00009537901,0.000007709633,0.00005623862,0.0000310125,0.00005669774],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05005017,"threshold_uncertainty_score":0.3282872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2944333322","doi":"10.1002/ejhf.1482","title":"The Clinical Significance of Interleukin-6 in Heart Failure: Results from the BIOSTAT-CHF Study","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":281,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada); Institute of Infection and Immunity","funders":"European Commission; National Institute for Health and Care Research; Singulex","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Natriuretic peptide; Cohort; Confidence interval; Cardiology","retraction":null,"screen_n_in":null,"score":{"opus":0.02324956178018966,"gpt":0.2692798672442682,"spread":0.2460303054640785,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005308414,0.0002255604,0.0005876286,0.00007758848,0.0001832616,0.00004449987,0.0008164895,0.0000929957,0.00007848637],"category_scores_gemma":[0.0008626588,0.0001233339,0.0002742092,0.0002308793,0.0003666728,0.0001288389,0.0001752507,0.001454888,0.0008120476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002499284,"about_ca_system_score_gemma":0.0001945368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008563226,"about_ca_topic_score_gemma":0.000352363,"domain_scores_codex":[0.9932185,0.004294177,0.001651111,0.000315339,0.0001379949,0.000382817],"domain_scores_gemma":[0.9965805,0.001775127,0.0006686001,0.0006928649,0.000236556,0.0000462939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003517215,0.000830363,0.1383611,0.00001117063,0.0004998473,0.0001085084,0.007159378,0.00002804737,0.1062551,0.00007021429,0.7411563,0.002002789],"study_design_scores_gemma":[0.004338315,0.002083609,0.1274333,0.0001470446,0.00003259526,0.00008695549,0.00715306,6.546508e-7,0.002636351,0.00002375359,0.8559272,0.0001371285],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822468,0.0008056982,0.00001027655,0.01418807,0.00164796,0.0004393289,0.0003382017,0.00001333493,0.0003103891],"genre_scores_gemma":[0.9983532,0.00006471322,0.0003550935,0.000489577,0.0002311318,0.000001067206,0.00001241111,0.00003001995,0.000462722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1147709,"threshold_uncertainty_score":0.9999659,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2044002436","doi":"10.1093/eurjhf/hfq042","title":"Does Cognitive Impairment Predict Poor Self-Care in Patients with Heart Failure?","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":272,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Health and Medical Research Council","keywords":"Medicine; Heart failure; Confidence interval; Cognition; Depression (economics); Multivariate analysis; Multivariate statistics; Internal medicine; Gerontology; Physical therapy; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.003602802006332376,"gpt":0.2121826916044937,"spread":0.2085798895981613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006801209,0.0003637888,0.0005970165,0.0003972942,0.0001121215,0.0000699771,0.0001467308,0.0000653322,0.0003642341],"category_scores_gemma":[0.0000693376,0.0001982789,0.0002213331,0.000281045,0.0001117187,0.0003065462,0.00008243977,0.0009305622,0.0001823844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001015464,"about_ca_system_score_gemma":0.0001775832,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004784745,"about_ca_topic_score_gemma":0.0000888107,"domain_scores_codex":[0.9974093,0.0003121138,0.0006744688,0.0003406134,0.0007673753,0.0004961342],"domain_scores_gemma":[0.9983962,0.00006137451,0.0002335753,0.0003052854,0.0005534632,0.0004500758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001281917,0.001269539,0.9048948,0.0001270021,0.0002888297,0.0004736703,0.001132212,0.00000252815,0.0003063022,0.00001197111,0.08960763,0.0006036048],"study_design_scores_gemma":[0.01076345,0.004807905,0.5397494,0.0005641862,0.0002572262,0.0001056368,0.001148123,0.000001779437,0.0003849854,0.000002295762,0.4420061,0.0002089013],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9680166,0.00004751076,0.00002470088,0.03008562,0.0003612238,0.001082523,0.00001822809,0.00007429783,0.0002893434],"genre_scores_gemma":[0.9641988,0.000005827994,0.03419193,0.0008533614,0.0004644968,0.00000700425,0.00003449147,0.00007633439,0.00016776],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3651453,"threshold_uncertainty_score":0.8085577,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2594341951","doi":"10.1002/ejhf.785","title":"Development and Validation of Multivariable Models to Predict Mortality and Hospitalization in Patients with Heart Failure","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"Sphingotec GmbH; Servier; British Heart Foundation; Pfizer; Vifor Pharma; National Institute for Health and Care Research; Amgen; Singulex; European Commission; Sanofi; Alere; Boston Scientific Corporation; Celladon Corporation","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Prospective cohort study; Cohort; Cardiology; Renal function; Cohort study","retraction":null,"screen_n_in":null,"score":{"opus":0.02473727814840365,"gpt":0.2539223482945352,"spread":0.2291850701461315,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006794,0.000148864,0.0003411316,0.0001652644,0.0001137398,0.0000592336,0.00006829117,0.00002744755,0.00001113657],"category_scores_gemma":[0.00006387776,0.0001099078,0.00002937655,0.00006911261,0.000058827,0.0004234263,0.00007988129,0.000120404,0.000002753892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004106669,"about_ca_system_score_gemma":0.00005994918,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001738254,"about_ca_topic_score_gemma":0.00002141382,"domain_scores_codex":[0.9987607,0.00009819784,0.0004469697,0.0001818482,0.000351406,0.0001608694],"domain_scores_gemma":[0.9991027,0.00001300151,0.0002411393,0.000244452,0.0002146968,0.0001840483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002142337,0.0002342844,0.9915745,0.00009510738,0.0000975334,0.00002174647,0.0009525857,0.0001699568,0.0003201803,0.00006119764,0.005750248,0.000508452],"study_design_scores_gemma":[0.004124202,0.0009132304,0.9548692,0.0006033729,0.00008599976,0.00001374699,0.0001765747,0.00005573435,0.001164621,0.00001096608,0.0378646,0.0001177914],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932343,0.00002280763,0.001070819,0.005031828,0.00003772693,0.0004904197,0.00000318419,0.000008074051,0.0001008],"genre_scores_gemma":[0.9031065,0.000004126017,0.09669361,0.0000753014,0.0000372332,0.000002044327,0.000009650108,0.00001944921,0.00005211884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09562279,"threshold_uncertainty_score":0.4481911,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255739262","doi":"10.1002/ejhf.1596","title":"Evaluation of the Effects of Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin on Morbidity and Mortality in Patients with Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR-Preserved Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"National Institute for Health and Care Research","keywords":"Empagliflozin; Medicine; Heart failure; Heart failure with preserved ejection fraction; Cardiology; Ejection fraction; Internal medicine; Diabetes mellitus; Type 2 diabetes; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.02195584523766419,"gpt":0.2525556766378853,"spread":0.2305998314002211,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00202692,0.0001200827,0.0003580273,0.00008786168,0.0000572955,0.00001094789,0.0000345617,0.00004504716,0.00001506301],"category_scores_gemma":[0.0001768543,0.00006328351,0.000126587,0.0001308094,0.0001044774,0.0001782518,0.0000124208,0.0002351306,1.655805e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005078712,"about_ca_system_score_gemma":0.0001710274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001862535,"about_ca_topic_score_gemma":0.00007187669,"domain_scores_codex":[0.9975275,0.001079003,0.0003834553,0.000151418,0.0007753259,0.00008329452],"domain_scores_gemma":[0.9987398,0.0001293438,0.0003529899,0.0002218573,0.0005080554,0.00004799229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01243176,0.0002289956,0.9723436,0.0003543568,0.0002606481,8.838078e-7,0.0001801494,0.0005260405,0.01306299,0.000001503441,0.0005393045,0.00006977559],"study_design_scores_gemma":[0.04122958,0.004468797,0.9352273,0.0006968498,0.0004962655,0.00001474338,0.00009634116,0.0001461143,0.01731493,0.000006425572,0.0002415929,0.00006101198],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996736,0.0001191453,0.0002020173,0.0004254287,0.0001187689,0.002382143,0.000009345079,0.000002735982,0.000004386146],"genre_scores_gemma":[0.99962,0.00001406508,0.0002258977,0.00002481705,0.00007801709,0.000007504041,0.000007152702,0.00001526556,0.000007339153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03711624,"threshold_uncertainty_score":0.2580627,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1995588280","doi":"10.1016/j.ejheart.2006.10.012","title":"Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM","year":2006,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster Children's Hospital; McMaster University Medical Centre; Hamilton General Hospital; Montreal Heart Institute","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Cardiology; Candesartan; Quality of life (healthcare); Heart failure with preserved ejection fraction; Population; Body mass index; Blood pressure","retraction":null,"screen_n_in":null,"score":{"opus":0.02116947431434819,"gpt":0.2580538181149971,"spread":0.2368843438006489,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001577225,0.0001902489,0.0007850831,0.0005025663,0.00003861295,0.00001245759,0.00006901769,0.00005817677,0.00008265228],"category_scores_gemma":[0.0001179129,0.0001552199,0.0001287542,0.0005325162,0.00004587687,0.0003529105,0.00002498393,0.0003678868,0.00001069532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001621534,"about_ca_system_score_gemma":0.0001363956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003400103,"about_ca_topic_score_gemma":0.0002686011,"domain_scores_codex":[0.9964249,0.0009301232,0.001663945,0.0001986452,0.0005365019,0.0002459466],"domain_scores_gemma":[0.9982892,0.0000552237,0.00102008,0.000218965,0.0003050489,0.0001114436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003615451,0.001628764,0.9705711,0.0003596085,0.0001065265,0.00001934597,0.0002020945,0.0001588025,0.01709936,0.00001754535,0.005837427,0.0003839961],"study_design_scores_gemma":[0.01223606,0.001806122,0.9720466,0.000712532,0.00003356945,0.00000533199,0.0001920442,0.00001910085,0.0008537681,0.000002548832,0.01198136,0.0001109434],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847624,0.00007200572,0.00009177093,0.01422965,0.0001489017,0.0006147011,0.000007355231,0.00001570633,0.00005745772],"genre_scores_gemma":[0.9968439,0.00001281572,0.002787171,0.00007963349,0.00008760242,0.000002590082,0.0001044154,0.00003283724,0.0000489877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01624559,"threshold_uncertainty_score":0.6329685,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2907436115","doi":"10.1002/ejhf.1366","title":"Adrenomedullin in Heart Failure: Pathophysiology and Therapeutic Application","year":2018,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":233,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Adrenomedullin; Medicine; Heart failure; Aldosterone; Internal medicine; Endocrinology; Volume overload; Pathophysiology; Pharmacology; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.03838939295368746,"gpt":0.2959196422182178,"spread":0.2575302492645303,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006596518,0.0004588918,0.001523854,0.0003467587,0.000114069,0.00006536538,0.000570032,0.0001166189,0.00004842284],"category_scores_gemma":[0.0001493796,0.0003364183,0.0004024106,0.0004291808,0.0003254958,0.0001189839,0.0002029509,0.001148623,0.0004907162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004013742,"about_ca_system_score_gemma":0.00013199,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001305826,"about_ca_topic_score_gemma":0.000002374078,"domain_scores_codex":[0.9950497,0.002516132,0.001143938,0.000638873,0.0002159797,0.0004353939],"domain_scores_gemma":[0.9982321,0.0003359157,0.0007775082,0.00039753,0.00007344277,0.0001834848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001754724,0.0004521361,0.00003502243,0.004356585,0.00007393517,0.0006701741,0.0002104072,0.000009808607,0.2521074,0.0006903769,0.06125388,0.6799648],"study_design_scores_gemma":[0.0002888282,0.0009043149,0.00008559823,0.001573368,0.00006279388,0.001088512,0.00001110341,0.000002504256,0.0001180061,0.0001927523,0.995388,0.000284169],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00358349,0.9936799,0.00001775253,0.001620557,0.0003402782,0.0006192143,0.00002339143,0.00003488036,0.00008050295],"genre_scores_gemma":[0.01200208,0.9834232,0.001334669,0.001662422,0.001349337,0.000008171054,0.000004755896,0.0001592206,0.00005610887],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9341342,"threshold_uncertainty_score":0.9999088,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072345235","doi":"10.1093/eurjhf/hft095","title":"Clinical Outcome Endpoints in Heart Failure Trials: A European Society of Cardiology Heart Failure Association Consensus Document","year":2013,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Clinical trial; Clinical endpoint; Intensive care medicine; Endpoint Determination; MEDLINE; Consistency (knowledge bases); Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05619077229551909,"gpt":0.344218265449564,"spread":0.2880274931540449,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01892114,0.0005878764,0.003049479,0.0004172238,0.0001339119,0.0001070347,0.0003179346,0.0002318026,0.0006120802],"category_scores_gemma":[0.002042519,0.0004536817,0.002129146,0.000452652,0.0002051804,0.0002889182,0.0002333403,0.001604493,0.0009913044],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003855738,"about_ca_system_score_gemma":0.000244772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003852233,"about_ca_topic_score_gemma":0.00002959579,"domain_scores_codex":[0.9848431,0.00815097,0.004444483,0.0006183073,0.001065915,0.0008771844],"domain_scores_gemma":[0.9952112,0.001138688,0.001562026,0.0007211326,0.0007461325,0.000620807],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001604135,0.0002252199,0.2903463,0.00009838509,0.000716968,0.0001833432,0.0002254212,0.00003425614,0.003144754,0.00001669183,0.7043033,0.0005449744],"study_design_scores_gemma":[0.008584773,0.001648229,0.1844548,0.0004284303,0.0004526337,0.0004973169,0.001170559,0.00001300929,0.000231897,0.00002815378,0.8021705,0.000319718],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5562244,0.0004702043,0.0002469089,0.4387278,0.001001835,0.002186865,0.00002643978,0.0001108285,0.001004664],"genre_scores_gemma":[0.8848243,0.00008396746,0.1087769,0.003077919,0.001837287,0.0000110619,0.00002742549,0.0001312992,0.001229846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4356499,"threshold_uncertainty_score":0.9997915,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969573398","doi":"10.1093/eurjhf/hfq230","title":"The Heart Failure Revascularisation Trial (HEART)","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Revascularization; Cardiology; Heart failure; Ejection fraction; Canadian Cardiovascular Society; Internal medicine; Coronary artery disease; Angina; Randomized controlled trial; Surgery; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.01009192818678306,"gpt":0.2563066971063803,"spread":0.2462147689195973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003240896,0.0001854529,0.0004187717,0.0001180278,0.0002963171,0.0001712377,0.0001569902,0.00006054945,0.00009797793],"category_scores_gemma":[0.002446686,0.0001215055,0.0005968576,0.0001803692,0.000150813,0.0001444993,0.00004897023,0.001436277,0.0003435849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002708173,"about_ca_system_score_gemma":0.0002203197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004557168,"about_ca_topic_score_gemma":0.000008315172,"domain_scores_codex":[0.9976929,0.0005401774,0.0006377933,0.0001775115,0.0006382835,0.0003133351],"domain_scores_gemma":[0.9980779,0.0004231793,0.0002132713,0.0005234132,0.0004530498,0.0003092173],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001526893,0.00009761864,0.009596992,0.000017019,0.0000909506,0.0001136743,0.0001527907,0.000009534769,0.01501644,0.00007536867,0.9724165,0.0008861635],"study_design_scores_gemma":[0.01315067,0.0006473998,0.03590715,0.0001147129,0.0001731979,0.002612569,0.0001834295,0.000007366538,0.0009816841,0.00002987262,0.9460685,0.0001234126],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7379353,0.001146194,0.0002727581,0.2546566,0.003971269,0.0005937032,0.000006183713,0.00007615339,0.001341807],"genre_scores_gemma":[0.9736731,0.00002582172,0.01823993,0.001907049,0.005725767,0.000001784333,0.000006236172,0.00006659471,0.0003537304],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2527496,"threshold_uncertainty_score":0.6239989,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2413467082","doi":"10.1002/ejhf.580","title":"Efficacy of Sacubitril/Valsartan vs. Enalapril at Lower than Target Doses in Heart Failure with Reduced Ejection Fraction: The PARADIGM-HF Trial","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Enalapril; Sacubitril, Valsartan; Valsartan; Sacubitril; Medicine; Hazard ratio; Heart failure; Internal medicine; Ejection fraction; Confidence interval; Randomized controlled trial; Cardiology; Angiotensin-converting enzyme; Blood pressure","retraction":null,"screen_n_in":null,"score":{"opus":0.01505950527721109,"gpt":0.2544469955928558,"spread":0.2393874903156447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001620874,0.0003583028,0.0009826696,0.0003478234,0.0001705436,0.00004462472,0.0001917484,0.00007721774,0.0006353187],"category_scores_gemma":[0.0002165341,0.0001780488,0.0004002538,0.0004463558,0.0001807736,0.0003311744,0.00006939418,0.0004882053,0.000181682],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002248916,"about_ca_system_score_gemma":0.0001842299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001126888,"about_ca_topic_score_gemma":0.00003684009,"domain_scores_codex":[0.9965454,0.0008686085,0.0009957633,0.0003530036,0.000794215,0.0004430472],"domain_scores_gemma":[0.9981332,0.0003183301,0.0005192432,0.0005618782,0.0002019232,0.0002654025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1424039,0.002258735,0.04440287,0.0001218245,0.0009821062,0.001176697,0.0007765844,0.00007162117,0.05825092,0.000106363,0.7480162,0.001432136],"study_design_scores_gemma":[0.0474048,0.005841341,0.05390124,0.0008912326,0.0002949822,0.0007913322,0.000266629,0.000002599914,0.008573314,0.00001207208,0.8817816,0.0002388003],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8649487,0.0002364995,0.0001597647,0.1327662,0.0004658919,0.001014802,0.000005353465,0.00003977235,0.0003630195],"genre_scores_gemma":[0.9911367,0.00005239146,0.006082221,0.0004124023,0.001176326,0.000007992641,0.000005696956,0.00006977322,0.001056464],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1337654,"threshold_uncertainty_score":0.7260619,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2971720436","doi":"10.1002/ejhf.1616","title":"Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 Years","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"Abbott Vascular; Hospices Civils de Lyon","keywords":"Medicine; Percutaneous; Mitral regurgitation; Heart failure; Cardiology; Internal medicine; Functional mitral regurgitation; MitraClip; Ejection fraction","retraction":null,"screen_n_in":null,"score":{"opus":0.01462467603724673,"gpt":0.31678052105095,"spread":0.3021558450137033,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002561751,0.0001610473,0.0004730224,0.00006527249,0.00005218036,0.00001750596,0.00006130889,0.00003645862,0.002202101],"category_scores_gemma":[0.0001175305,0.0001013594,0.002136547,0.00005426604,0.00003328862,0.00006687696,0.00002432546,0.0001280765,0.0003434561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000170397,"about_ca_system_score_gemma":0.000289006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002052215,"about_ca_topic_score_gemma":0.000002630479,"domain_scores_codex":[0.9986711,0.0001239202,0.0004041094,0.0001748845,0.0004203701,0.0002056263],"domain_scores_gemma":[0.9989769,0.0001443227,0.000128074,0.0002330948,0.0001304778,0.0003870807],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005578136,0.0007841381,0.6983452,0.0001696374,0.005063734,0.01288818,0.000702645,0.00001218781,0.0003445796,0.0000244845,0.2658924,0.01019461],"study_design_scores_gemma":[0.008066812,0.004365116,0.4825667,0.0001751885,0.0007798844,0.008422229,0.0002937433,0.000008334374,0.00002289118,0.000003956113,0.495167,0.0001281988],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911181,0.000659227,0.000003560594,0.006528082,0.0004164617,0.0003719901,0.00004046212,0.00003242225,0.0008296832],"genre_scores_gemma":[0.9841434,0.00005067599,0.004752286,0.0009849428,0.0003876557,0.000001771263,0.00003545445,0.00005104816,0.0095928],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2292745,"threshold_uncertainty_score":0.99871,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386758072","doi":"10.1002/ejhf.3036","title":"Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress Using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Medicine; Statement (logic); Cardiology; Internal medicine; Algorithm; Intensive care medicine; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.07453152896729641,"gpt":0.360294006343419,"spread":0.2857624773761226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004942253,0.0003892046,0.001157759,0.0001828221,0.000302805,0.0001060292,0.0002229866,0.0001554906,0.00008973887],"category_scores_gemma":[0.001735548,0.0002430902,0.0007542325,0.0005104275,0.0002785923,0.0002040195,0.0002541794,0.0008799746,0.00003314584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001402091,"about_ca_system_score_gemma":0.0003631046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000119458,"about_ca_topic_score_gemma":0.0001263508,"domain_scores_codex":[0.9939525,0.001908361,0.001909316,0.0004544612,0.001175445,0.0005999312],"domain_scores_gemma":[0.9948392,0.002422272,0.001040453,0.0006119053,0.0007480275,0.0003381774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002595788,0.0003610456,0.3684533,0.0001044598,0.0007037221,0.00004937105,0.0004593718,0.00004810955,0.001511513,0.0000284536,0.6278411,0.0001799399],"study_design_scores_gemma":[0.005827269,0.002073313,0.2835982,0.001189753,0.00120349,0.0001580045,0.002773423,0.0003295706,0.002137366,0.00005211452,0.7003873,0.000270212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.650328,0.0001795067,0.0001319615,0.347451,0.0004092258,0.001288955,0.000168257,0.00003420757,0.000008822201],"genre_scores_gemma":[0.8635536,0.00009077627,0.1334591,0.001433614,0.00105182,0.00002287658,0.00003343588,0.0001141176,0.0002405875],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3460174,"threshold_uncertainty_score":0.9912932,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2913730011","doi":"10.1002/ejhf.1379","title":"Lung Ultrasound Integrated with Clinical Assessment for the Diagnosis of Acute Decompensated Heart Failure in the Emergency Department: A Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Emergency department; Acute decompensated heart failure; Heart failure; Randomized controlled trial; Intensive care medicine; Lung ultrasound; Emergency medicine; Ultrasound; Cardiology; Lung; Internal medicine; Radiology","retraction":null,"screen_n_in":null,"score":{"opus":0.02469754539882701,"gpt":0.3634751226027916,"spread":0.3387775772039646,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01277289,0.0002994111,0.002276536,0.0001275761,0.0001219751,0.00005345198,0.0004805682,0.00008734975,0.0006571765],"category_scores_gemma":[0.002541133,0.0001269542,0.001408403,0.0004495711,0.0002662431,0.0001146151,0.00003005236,0.001161915,0.00002451006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004788348,"about_ca_system_score_gemma":0.0003412319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006258887,"about_ca_topic_score_gemma":0.00002909167,"domain_scores_codex":[0.9922797,0.003314658,0.003113271,0.0003045847,0.0006662612,0.0003215077],"domain_scores_gemma":[0.980884,0.01636113,0.001282495,0.0006122277,0.0007002977,0.0001598325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7976303,0.001832788,0.1009152,0.00004197252,0.003497423,0.00001968654,0.0002629849,0.00005000231,0.0007359008,0.0002780662,0.09465279,0.00008288308],"study_design_scores_gemma":[0.8838566,0.003964467,0.02967304,0.000263569,0.002824588,0.0002704381,0.0005239826,0.0001861615,0.00004571885,0.00007068506,0.07815132,0.0001694585],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9396067,0.0002470436,0.002216528,0.04611409,0.0005099346,0.01107248,0.0000412722,0.00001755691,0.0001744266],"genre_scores_gemma":[0.975273,0.0002895867,0.02248841,0.0009372637,0.0004573116,0.0003575116,0.00003857163,0.00005089849,0.0001074232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08622628,"threshold_uncertainty_score":0.7195622,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W1870916828","doi":"10.1002/ejhf.29","title":"Analysing Recurrent Hospitalizations in Heart Failure: A Review of Statistical Methodology, with Application to CHARM-Preserved","year":2013,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Medical Research Council; National Institute for Health and Care Research; AstraZeneca","keywords":"Heart failure; Candesartan; Medicine; Hazard ratio; Confidence interval; Internal medicine; Proportional hazards model; Placebo; Cardiology; Blood pressure; Angiotensin II","retraction":null,"screen_n_in":null,"score":{"opus":0.0712695524200134,"gpt":0.3777123776398205,"spread":0.3064428252198071,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003096582,0.0005106034,0.003353417,0.001044156,0.00005372116,0.00003580652,0.000293042,0.00008990657,0.0003340075],"category_scores_gemma":[0.0006274055,0.0003393176,0.0005673831,0.001514405,0.00008812975,0.0001420384,0.0001315414,0.0007383664,0.0001867907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001855602,"about_ca_system_score_gemma":0.0003492044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001506404,"about_ca_topic_score_gemma":0.00002220986,"domain_scores_codex":[0.9938091,0.002573741,0.002123297,0.0004629717,0.000636334,0.0003945535],"domain_scores_gemma":[0.9970741,0.0003077048,0.0009460635,0.0006883595,0.0005499658,0.0004338167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008752591,0.0006686168,0.0003877881,0.07873151,0.001207637,0.0002796142,0.0001414461,0.000009503794,0.00002766175,0.000322318,0.6672335,0.2509028],"study_design_scores_gemma":[0.0006311291,0.001153676,0.0001655802,0.09547397,0.002352375,0.0003580758,0.00004669477,0.000004120819,0.000002652009,0.000004772515,0.8995678,0.0002391098],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001540801,0.9505031,0.01765866,0.02848208,0.00008241223,0.003125341,0.00003016312,0.00002307964,0.00007975127],"genre_scores_gemma":[0.00002586325,0.6835428,0.3154403,0.000415903,0.000185064,0.00006030405,0.0001541866,0.00008432951,0.00009124111],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2977816,"threshold_uncertainty_score":0.9999059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2115305066","doi":"10.1016/j.ejheart.2007.12.010","title":"Heart Failure with Preserved Ejection Fraction: Clinical Characteristics of 4133 Patients Enrolled in the I-PRESERVE Trial","year":2008,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"University of Hull","keywords":"Heart failure; Medicine; Ejection fraction; Cardiology; Internal medicine; Clinical trial; Stroke volume","retraction":null,"screen_n_in":null,"score":{"opus":0.03835795492669395,"gpt":0.2901750026843425,"spread":0.2518170477576485,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002278549,0.0002445565,0.0008293503,0.0002426164,0.0001357654,0.00003154441,0.0002210535,0.00007543327,0.0001853473],"category_scores_gemma":[0.0004323516,0.0001449387,0.0003817374,0.0003725794,0.0001387842,0.0002910024,0.00005918109,0.000824975,0.00005586836],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005291938,"about_ca_system_score_gemma":0.0001525406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001143893,"about_ca_topic_score_gemma":0.00001640011,"domain_scores_codex":[0.9957096,0.001519039,0.001378467,0.0002456736,0.0008576693,0.0002895464],"domain_scores_gemma":[0.9980525,0.0002450127,0.0005981177,0.0004756757,0.000444488,0.0001841604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02221148,0.002230131,0.6849707,0.00006310964,0.000268856,0.0005319882,0.0003193303,0.000008395681,0.0001080241,0.000006560616,0.2890499,0.0002315248],"study_design_scores_gemma":[0.04355309,0.007279665,0.5557877,0.0002170447,0.000172487,0.0002316078,0.0003243069,0.000009946435,0.00004693306,0.000002234989,0.3922577,0.0001173417],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747776,0.00004062761,0.00008461637,0.02330876,0.0003228759,0.001053653,0.000004672641,0.00001831961,0.0003888497],"genre_scores_gemma":[0.9899974,0.00003629328,0.008154218,0.0005155219,0.0009789695,0.000006968202,0.00002024387,0.00003891571,0.0002514528],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.129183,"threshold_uncertainty_score":0.5910431,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2342809951","doi":"10.1002/ejhf.531","title":"A Systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: Rationale, Design, and Baseline Characteristics of BIOSTAT-CHF","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"European Commission; National Institute for Health and Care Research","keywords":"Heart failure; Medicine; Cohort; Ejection fraction; Intensive care medicine; Heart failure with preserved ejection fraction; Internal medicine; Cohort study; Cardiology","retraction":null,"screen_n_in":null,"score":{"opus":0.02496882518428697,"gpt":0.2743183436128386,"spread":0.2493495184285517,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001705231,0.0002809629,0.0008197794,0.0004992184,0.00005150509,0.00002860281,0.00009226611,0.000034818,0.00007998152],"category_scores_gemma":[0.0001856824,0.0001678262,0.0001169014,0.0002477177,0.00007091928,0.0001231787,0.00005908239,0.0001268448,0.00007239218],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000285318,"about_ca_system_score_gemma":0.0002485568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002528842,"about_ca_topic_score_gemma":0.00004047343,"domain_scores_codex":[0.9969882,0.001106285,0.001013354,0.0002975229,0.0002704825,0.000324105],"domain_scores_gemma":[0.9986247,0.0002359203,0.0002642274,0.0003071436,0.0002696594,0.0002982809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004630924,0.006100233,0.3780351,0.0004226151,0.001925198,0.002629061,0.003860462,0.0001784513,0.3628508,0.000266951,0.2194284,0.01967178],"study_design_scores_gemma":[0.01681349,0.03159557,0.1107121,0.001210161,0.0004076499,0.0006357094,0.001181151,0.00007750947,0.002302345,0.000007325048,0.8346754,0.0003816106],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9179216,0.0006486867,0.00691367,0.07131245,0.0002276711,0.00290384,0.00002738108,0.00002820991,0.00001649426],"genre_scores_gemma":[0.9814371,0.0000751327,0.01753537,0.0001797106,0.0003565024,0.00001778281,0.000008999907,0.00004079095,0.000348638],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.615247,"threshold_uncertainty_score":0.6843756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1810606235","doi":"10.1002/ejhf.332","title":"Signature of Circulating microRNAs in Patients with Acute Heart Failure","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":203,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"Novartis Pharma; Nederlandse Federatie van Universitair Medische Centra; ZonMw; National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Exacerbation; Cohort; microRNA; COPD; Internal medicine; Cohort study; Cardiology; Oncology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.006385251198274522,"gpt":0.2122621925242935,"spread":0.2058769413260189,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004919682,0.0001662019,0.0002492682,0.0001129338,0.00002771364,0.00002129329,0.0001872168,0.00006912257,0.00001199228],"category_scores_gemma":[0.00009735942,0.0001361249,0.0001152376,0.000156641,0.00007380341,0.00001952849,0.00006904945,0.0002453258,0.00000689278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002747038,"about_ca_system_score_gemma":0.0001459517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001184627,"about_ca_topic_score_gemma":0.000003913771,"domain_scores_codex":[0.9985459,0.0003155413,0.0004583552,0.0001857405,0.0002953097,0.0001991336],"domain_scores_gemma":[0.9987631,0.000009009247,0.0003455356,0.000249645,0.000464705,0.0001680463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0006845829,0.0002224936,0.1173932,0.00003480264,0.000193527,0.00006372877,0.0002279946,0.002303311,0.798223,0.000006386445,0.08047385,0.0001732039],"study_design_scores_gemma":[0.01409961,0.003743766,0.6023504,0.0008641269,0.0002200949,0.000768345,0.0005411102,0.00003262464,0.1371914,0.00003380605,0.2392305,0.0009242211],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981019,0.0003930508,0.0003208345,0.0009143262,0.00008561274,0.0001282835,0.00001386869,0.000003886421,0.00003818765],"genre_scores_gemma":[0.9863592,0.000001282078,0.01324301,0.0001078606,0.0001865027,3.631438e-7,0.00003992875,0.00004069526,0.00002114664],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6610315,"threshold_uncertainty_score":0.5551014,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2900196560","doi":"10.1002/ejhf.1311","title":"Impact of Exercise-Based Cardiac Rehabilitation in Patients with Heart Failure (ExTraMATCH II) on Mortality and Hospitalisation: An Individual Patient Data Meta-Analysis of Randomised Trials","year":2018,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Care","funders":"Keele University; Department of Health and Social Care; National Center for Complementary and Integrative Health; National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Rehabilitation; Meta-analysis; Physical therapy; Patient data; Emergency medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1496875701543363,"gpt":0.4155559527983987,"spread":0.2658683826440624,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01432681,0.0005601054,0.009980502,0.001220659,0.00008520552,0.00003036937,0.000259205,0.0001613485,0.0001022961],"category_scores_gemma":[0.001069992,0.0003336661,0.003524509,0.001038522,0.000179772,0.0002798432,0.00008360391,0.0006486798,0.00000183122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000192151,"about_ca_system_score_gemma":0.001363033,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001137509,"about_ca_topic_score_gemma":0.00002007583,"domain_scores_codex":[0.9866015,0.006887129,0.004128974,0.0005911223,0.001434023,0.0003572566],"domain_scores_gemma":[0.992783,0.001026666,0.00348766,0.001342887,0.0007228042,0.0006369866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.04803075,0.01193359,0.4159862,0.06648939,0.2766857,0.00008233028,0.006260886,0.0003187009,0.000007010246,0.000004857669,0.09090102,0.08329958],"study_design_scores_gemma":[0.0278958,0.03782739,0.3527492,0.0111195,0.4735288,0.00002002043,0.0003346514,0.000006248536,0.000004179956,0.000001553776,0.09586235,0.0006502779],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6249425,0.3642692,0.000007140244,0.0005848152,0.0001936845,0.0058168,0.004162733,0.0000115504,0.00001162045],"genre_scores_gemma":[0.814371,0.1517392,0.02183172,0.0003089948,0.0007052975,0.00009186785,0.01059837,0.0003456048,0.000007904055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.21253,"threshold_uncertainty_score":0.9999115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4377099139","doi":"10.1002/ejhf.2894","title":"Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Surgical Specialties (Canada)","funders":"European Society of Cardiology","keywords":"Medicine; Heart failure; Heart failure with preserved ejection fraction; Internal medicine; Ejection fraction; Cardiology; Diastolic heart failure; Diastole; Polypharmacy; Intensive care medicine; Blood pressure","retraction":null,"screen_n_in":null,"score":{"opus":0.02346337715669502,"gpt":0.2615189731264118,"spread":0.2380555959697167,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01845029,0.0003679323,0.0008729848,0.0001885355,0.0005251126,0.00009002202,0.0003655763,0.00007202275,0.00001147882],"category_scores_gemma":[0.0006340406,0.0001834701,0.0007676058,0.001387573,0.0003192669,0.0002303142,0.0004829979,0.0008104014,0.00001866297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003395767,"about_ca_system_score_gemma":0.0001845635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004000412,"about_ca_topic_score_gemma":0.00006950355,"domain_scores_codex":[0.9878284,0.007871793,0.001737645,0.0004693069,0.001606518,0.0004863371],"domain_scores_gemma":[0.9954804,0.0006249098,0.001648965,0.0008679082,0.001273319,0.0001045246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0005776862,0.0002996462,0.2675631,0.0002841717,0.001075172,0.0000119102,0.004548658,0.005359419,0.05104378,0.00002063058,0.6675308,0.00168505],"study_design_scores_gemma":[0.004736787,0.0008880072,0.6242446,0.001707511,0.0005779547,0.00009365956,0.00670966,0.0003688261,0.002796857,0.00003273067,0.3576104,0.0002329771],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8809744,0.0002718144,0.0005266453,0.1148619,0.00049678,0.002347395,0.00002968817,0.00004646906,0.0004449599],"genre_scores_gemma":[0.990644,0.00006010423,0.007794002,0.0008122398,0.0002871246,0.000006450949,0.0000114889,0.00009240972,0.0002921603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3566816,"threshold_uncertainty_score":0.7481694,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4367183877","doi":"10.1002/ejhf.2874","title":"Worsening of Chronic Heart Failure: Definition, Epidemiology, Management and Prevention. A Clinical Consensus Statement by the Heart Failure Association of the European Society of Cardiology","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Abbott Vascular; Servier; Stockholms Läns Landsting; Respicardia; Queen's University; Deutsche Forschungsgemeinschaft; University of Glasgow; Pfizer; Moderna; Idorsia Pharmaceuticals; Karolinska Institutet; Impulse Dynamics; Novo Nordisk; MyoKardia; ReCor Medical; British Heart Foundation; Vetenskapsrådet; Cytokinetics; European Commission; Sanofi; Gedeon Richter; LivaNova; Deutsches Zentrum für Herz-Kreislaufforschung; Queen's University Belfast; Boston Scientific Corporation; Helsinn; Alnylam Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Chugai Pharmaceutical; Vifor Pharma; Ministero della Salute; Abbott Laboratories","keywords":"Medicine; Heart failure; Intensive care medicine; Guideline; Diuretic; Epidemiology; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.05207939590835027,"gpt":0.321903332460545,"spread":0.2698239365521947,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01406802,0.0002923807,0.001147119,0.0001476178,0.0001970014,0.00001242405,0.0002386274,0.00009357226,0.00004103687],"category_scores_gemma":[0.0005026111,0.0001848052,0.0009235453,0.0004879504,0.0004482017,0.00007451452,0.0003160982,0.0006658919,0.00003409452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001380879,"about_ca_system_score_gemma":0.0001371456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009104102,"about_ca_topic_score_gemma":0.0000154886,"domain_scores_codex":[0.9906611,0.005644287,0.00229499,0.0003499101,0.0005710673,0.000478671],"domain_scores_gemma":[0.9965536,0.0009040678,0.0014489,0.0005385488,0.0003890489,0.0001658138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007519909,0.0001180381,0.1182484,0.000253386,0.0012874,0.00001857896,0.000193188,0.0001337664,0.001448365,0.0001365791,0.877483,0.0006041288],"study_design_scores_gemma":[0.003822808,0.001382058,0.1900493,0.0007446598,0.0007985522,0.0001922225,0.001633154,0.00003367175,0.0002509416,0.0001504449,0.800787,0.0001551704],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.4936224,0.002073826,0.00116837,0.4991283,0.0007152493,0.002219693,0.00009385528,0.00008593292,0.0008924001],"genre_scores_gemma":[0.9604248,0.0005904294,0.03625497,0.0009132928,0.0005115065,0.0000083919,0.00004089609,0.00007041321,0.001185262],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.498215,"threshold_uncertainty_score":0.7536137,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2996500186","doi":"10.1002/ejhf.1673","title":"European Society of Cardiology/Heart Failure Association Position Paper on the Role and Safety of New Glucose-Lowering Drugs in Patients with Heart Failure","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Pfizer; Servier; Boston Scientific Corporation; Sanofi; AstraZeneca","keywords":"Dapagliflozin; Empagliflozin; Medicine; Heart failure; Saxagliptin; Canagliflozin; Ejection fraction; Internal medicine; Cardiology; Liraglutide; Type 2 diabetes; Benzhydryl compounds; Diabetes mellitus; Intensive care medicine; Sitagliptin; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.003845443169605257,"gpt":0.186350849677464,"spread":0.1825054065078587,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001292942,0.0002214597,0.0005751954,0.0001147638,0.00006072563,0.00002629739,0.0001121626,0.00004938205,0.00006273672],"category_scores_gemma":[0.00003965708,0.000144523,0.0002439814,0.0001904129,0.00005434405,0.0002177363,0.0000747176,0.0004228076,0.00003759773],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001218052,"about_ca_system_score_gemma":0.00004826279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005119484,"about_ca_topic_score_gemma":0.000003080706,"domain_scores_codex":[0.9979621,0.0004691736,0.0005635548,0.000217707,0.0005194985,0.0002679893],"domain_scores_gemma":[0.9988858,0.00009877402,0.000408267,0.0002803491,0.0002089279,0.0001178491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005397557,0.0001694555,0.9016491,0.00008101103,0.0004753587,0.000005736559,0.0008372921,0.0001511649,0.00965548,0.00004246411,0.08571533,0.0006779133],"study_design_scores_gemma":[0.004947212,0.002055307,0.7822056,0.0007477004,0.0001764721,0.0000105803,0.000909368,0.000004517989,0.001065215,0.000009375139,0.2077364,0.0001321884],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9758358,0.0001406578,0.0000156649,0.022239,0.00007638377,0.0004989619,0.000008877704,0.00001320159,0.001171476],"genre_scores_gemma":[0.9959434,0.00002493872,0.002723951,0.0007919426,0.0001660556,6.954544e-7,0.00001890676,0.00004658581,0.0002834993],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1220211,"threshold_uncertainty_score":0.5893478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2044348391","doi":"10.1093/eurjhf/hft028","title":"Heart Failure in Elderly Patients: Distinctive Features and Unresolved Issues","year":2013,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Medicine; Heart failure; Clinical trial; Epidemiology; Intensive care medicine; Ageing; Gerontology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02264473105485326,"gpt":0.2960552315284893,"spread":0.273410500473636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008851266,0.0007833106,0.002791333,0.0007375436,0.0001111233,0.0001655635,0.0002377944,0.0001913226,0.0002795497],"category_scores_gemma":[0.0002352079,0.0005236136,0.0007017299,0.0004004596,0.0001379166,0.0003071174,0.0001828241,0.001456161,0.0003233089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001768512,"about_ca_system_score_gemma":0.0001780132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002380278,"about_ca_topic_score_gemma":0.00004339695,"domain_scores_codex":[0.9957108,0.001156053,0.001417107,0.0005262209,0.0006300142,0.0005597352],"domain_scores_gemma":[0.9979225,0.0001707985,0.0006153462,0.0004830665,0.0003277072,0.0004805482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006173449,0.0003800123,0.001628855,0.003706985,0.0004875294,0.0005556907,0.0002378196,3.026253e-7,0.000002396328,0.00002333199,0.8045116,0.1884037],"study_design_scores_gemma":[0.002205653,0.001941499,0.003266301,0.01563824,0.0009865708,0.0007350899,0.0002002552,2.504303e-7,0.000001307833,0.00000690395,0.9746238,0.0003941363],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005759225,0.9778272,0.000009489971,0.01901923,0.0002814239,0.00187042,0.00002135211,0.00004530232,0.0003496468],"genre_scores_gemma":[0.0006163223,0.9614096,0.03299818,0.0004621093,0.001229411,0.00003061307,0.0001412666,0.0002660281,0.002846516],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1880096,"threshold_uncertainty_score":0.9997215,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2914497003","doi":"10.1002/ejhf.1402","title":"Reduced Loop Diuretic Use in Patients Taking Sacubitril/Valsartan Compared with Enalapril: The PARADIGM-HF Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"U.S. Department of Veterans Affairs","keywords":"Enalapril; Diuretic; Medicine; Loop diuretic; Sacubitril; Furosemide; Valsartan; Heart failure; Sacubitril, Valsartan; Bumetanide; Randomization; Internal medicine; Randomized controlled trial; Cardiology; Ejection fraction; Angiotensin-converting enzyme; Blood pressure; Sodium; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.0237861014931983,"gpt":0.2496299538296727,"spread":0.2258438523364744,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009641648,0.0002800403,0.0007699041,0.0002510272,0.00008713969,0.000112102,0.0002000955,0.00003565438,0.0002043992],"category_scores_gemma":[0.0001282782,0.0001580478,0.0002067282,0.0003408167,0.00007295895,0.0002756683,0.00005813748,0.0005748969,0.0001944448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008711031,"about_ca_system_score_gemma":0.0001221178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001087304,"about_ca_topic_score_gemma":0.00001663134,"domain_scores_codex":[0.9971844,0.0006858187,0.0007722715,0.000260984,0.0006946645,0.0004018408],"domain_scores_gemma":[0.9985312,0.0001469108,0.0004721021,0.0004777899,0.0001601824,0.0002117746],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06469906,0.002243476,0.7741651,0.0001461091,0.0008264444,0.001594756,0.001961387,0.0003521362,0.002165927,0.0002409434,0.1501806,0.001424055],"study_design_scores_gemma":[0.1210053,0.007643012,0.5046196,0.001250478,0.0004648982,0.0002725087,0.0004390409,0.00005652169,0.00035245,0.000008257182,0.3635069,0.0003810876],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9834656,0.00009020139,0.00002455075,0.01438672,0.000335855,0.001289233,0.000002133661,0.00002350874,0.0003821956],"genre_scores_gemma":[0.9954812,0.000008734153,0.002817548,0.0006376014,0.0002998383,0.00000273617,0.00001074374,0.00005911448,0.0006825185],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2695455,"threshold_uncertainty_score":0.6445,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1596067399","doi":"10.1002/ejhf.115","title":"Baseline Characteristics and Treatment of Patients in Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Servier; University of Glasgow; Pfizer; Amgen","keywords":"Medicine; Heart failure; Ejection fraction; Enalapril; Internal medicine; Cardiology; Natriuretic peptide; Randomized controlled trial; Clinical trial; Angiotensin-converting enzyme; Blood pressure","retraction":null,"screen_n_in":null,"score":{"opus":0.03191936138850019,"gpt":0.3154298619205974,"spread":0.2835105005320972,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007338569,0.0002866523,0.001108457,0.0002240342,0.00002782259,0.00001887276,0.00005565749,0.00004117886,0.00001653628],"category_scores_gemma":[0.0001494849,0.0001856837,0.0001092634,0.0002305591,0.00008311447,0.00009957301,0.00003397927,0.0001769431,0.000002944347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000191323,"about_ca_system_score_gemma":0.0000689606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001170263,"about_ca_topic_score_gemma":0.0004704391,"domain_scores_codex":[0.9977915,0.0004692473,0.0008522522,0.0002619588,0.0003764936,0.0002485526],"domain_scores_gemma":[0.9988924,0.00009740438,0.0003516083,0.0002478073,0.0001389904,0.0002717956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01610686,0.002059821,0.9772269,0.00005811405,0.0001307505,0.00007969417,0.0004902345,0.00003938982,0.0001397602,0.000009155406,0.001902315,0.001756969],"study_design_scores_gemma":[0.0331766,0.02658117,0.9301952,0.0003879389,0.0001507562,0.00003661382,0.00008617016,0.0000977057,0.000288719,0.00000403646,0.008865177,0.0001299257],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994804,0.00003597663,0.00004394856,0.003913068,0.00005241239,0.001071774,0.00004217796,0.000006475833,0.00003011991],"genre_scores_gemma":[0.9952422,0.00001428852,0.004491634,0.00006430977,0.00013632,0.000004453235,0.00001539211,0.00002044958,0.00001096872],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04703176,"threshold_uncertainty_score":0.7571963,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3084074131","doi":"10.1002/ejhf.1994","title":"Integration of a Palliative Approach into Heart Failure Care: A European Society of Cardiology Heart Failure Association Position Paper","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Care Foundation","funders":"European Society of Cardiology","keywords":"Medicine; Palliative care; Heart failure; Psychosocial; Guideline; Position paper; Intensive care medicine; Position (finance); Disease; Disease management; Advance care planning; Nursing; Cardiology; Internal medicine; Psychiatry; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01810945208394496,"gpt":0.2511828807114989,"spread":0.233073428627554,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001552105,0.0004284808,0.001251071,0.0001945832,0.000146586,0.00004688965,0.0002149389,0.0001452971,0.00008103268],"category_scores_gemma":[0.0002641478,0.000348627,0.001013581,0.0005383141,0.000127052,0.0003803333,0.000132489,0.0008787367,0.00007801805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003168467,"about_ca_system_score_gemma":0.0001821226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001778969,"about_ca_topic_score_gemma":0.00001094381,"domain_scores_codex":[0.9952541,0.001687828,0.001319578,0.0004474621,0.0008750614,0.0004159526],"domain_scores_gemma":[0.9972491,0.0001136904,0.0008392182,0.0003637205,0.001073356,0.0003608919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003785129,0.0002135983,0.02453411,0.000537633,0.0010179,0.00005515984,0.009279775,0.0002328729,0.2224568,0.00008250817,0.7406922,0.0005188916],"study_design_scores_gemma":[0.005446624,0.004328394,0.05497415,0.0006942146,0.0009439521,0.0001628795,0.0123591,0.0001035409,0.006901937,0.0000176147,0.9136508,0.0004167884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3136809,0.001568497,0.01966872,0.6588333,0.0004530969,0.002648012,0.00009319985,0.0002211287,0.002833108],"genre_scores_gemma":[0.8324863,0.00004599505,0.1639096,0.002364888,0.0009029916,0.000004637022,0.0001221249,0.00008165259,0.00008173961],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6564685,"threshold_uncertainty_score":0.9998966,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2746903407","doi":"10.1002/ejhf.933","title":"Moderated ePoster Session 2","year":2014,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute on Aging; Medical Research Council; Sundhedsvidenskabelige Fakultet, Aarhus Universitet; National Institutes of Health; H. Lundbeck A/S; Hjartavernd; Lundbeckfonden; Institut National de la Santé et de la Recherche Médicale; Aarhus Universitet; Université de Lille; Wellcome Trust; Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease; Centre hospitalier régional universitaire de Lille; Danmarks Frie Forskningsfond; Erasmus Medisch Centrum; Novo Nordisk; Bundesministerium für Bildung und Forschung; National Heart, Lung, and Blood Institute; Villum Fonden","keywords":"Empagliflozin; Medicine; Heart failure; Canagliflozin; Diabetes mellitus; Internal medicine; Intensive care medicine; Clinical trial; Disease; Type 2 Diabetes Mellitus; Cardiology; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.03160162829318401,"gpt":0.3044704430443936,"spread":0.2728688147512096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007210885,0.0003329717,0.001692723,0.0002971511,0.0000498019,0.00006125784,0.0001488842,0.00006169084,0.0002094],"category_scores_gemma":[0.0000427155,0.0001978029,0.0007563747,0.0001438222,0.0000253884,0.0000812503,0.00007902056,0.0005268396,0.0007592953],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006437869,"about_ca_system_score_gemma":0.0000985577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":1.160597e-7,"about_ca_topic_score_gemma":1.07577e-7,"domain_scores_codex":[0.9978329,0.0005909358,0.0008454644,0.0001857148,0.0003199556,0.0002250608],"domain_scores_gemma":[0.9987078,0.00004014899,0.0005720428,0.0003129771,0.0001438392,0.0002231366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001721163,0.00009478941,0.000009408622,0.004888464,0.0004767789,0.0005551488,0.00001624292,7.077471e-7,0.000002437,0.000007461399,0.3083967,0.6855347],"study_design_scores_gemma":[0.00082821,0.0007113458,0.00001513487,0.02731752,0.002154578,0.000738785,0.000005103987,0.000001626804,0.000001759213,0.000002298702,0.968072,0.0001516644],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002131669,0.9937741,0.00008816607,0.001402226,0.0003391367,0.0003605784,0.000002433988,0.00002548129,0.003986594],"genre_scores_gemma":[0.00009710604,0.9893108,0.004686499,0.0004172174,0.0009058252,0.000001611077,0.00004541559,0.0001149078,0.004420631],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.685383,"threshold_uncertainty_score":0.9759458,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016426161","doi":"10.1093/eurjhf/hfs192","title":"Hyperpolarized 13C Magnetic Resonance Reveals Early- and Late-Onset Changes to <i>in vivo</i> Pyruvate Metabolism in the Failing Heart","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Advanced NMR Techniques and Applications","field":"Chemistry","cited_by":162,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Alberta; General Electric (Canada); University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; British Heart Foundation","keywords":"Heart failure; Medicine; In vivo; Nuclear magnetic resonance; Magnetic resonance imaging; Internal medicine; Biology; Physics; Radiology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01328830649218389,"gpt":0.2515200589361624,"spread":0.2382317524439785,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00126996,0.0001653525,0.0002979144,0.0001039562,0.00008702487,0.00005180945,0.0002656122,0.00003985382,0.00007886239],"category_scores_gemma":[0.00008325403,0.000124516,0.0000608296,0.000260336,0.00004774161,0.0001763189,0.00007522085,0.0005358421,0.00001565449],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000185348,"about_ca_system_score_gemma":0.00001034189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001470924,"about_ca_topic_score_gemma":0.00002021923,"domain_scores_codex":[0.9986297,0.000213513,0.0004206487,0.0001639503,0.0002065985,0.0003655991],"domain_scores_gemma":[0.99928,0.0001117409,0.0001230574,0.0002912871,0.00004936588,0.000144575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001215378,0.0001460613,0.03931919,0.00004853798,0.000007484467,0.0000643349,0.002919102,0.0000189769,0.9348587,0.0001634215,0.0187071,0.003625486],"study_design_scores_gemma":[0.0005475981,0.00006011929,0.04556412,0.0002225896,0.00001491415,0.0002198832,0.0002918613,0.000005975461,0.0121708,0.0001144944,0.9406111,0.0001765239],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9795792,0.005516834,0.00005933223,0.01423251,0.00002122575,0.0001472312,0.00001967733,0.00002227711,0.0004017258],"genre_scores_gemma":[0.9719283,0.0002112702,0.02554105,0.001665642,0.0002840456,0.00001036708,9.076508e-7,0.00003754242,0.0003208926],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9226879,"threshold_uncertainty_score":0.5077613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}